200 related articles for article (PubMed ID: 30981742)
1. Heart Failure Site-Based Research in the United States: Results of the Heart Failure Society of America Research Network Survey.
Psotka MA; Ammon SE; Fiuzat M; Bozkurt B; Chung ES; Cole RT; Greene SJ; Kraus D; Ky B; McIlvennan CK; Shah P; Teerlink JR; Walsh MN; Jessup M; O'Connor CM
JACC Heart Fail; 2019 May; 7(5):431-438. PubMed ID: 30981742
[TBL] [Abstract][Full Text] [Related]
2. ACCF/AHA/HFSA 2011 survey results: current staffing profile of heart failure programs, including programs that perform heart transplant and mechanical circulatory support device implantation.
Jessup M; Albert NM; Lanfear DE; Lindenfeld J; Massie BM; Walsh MN; Zucker MJ; ; ;
J Card Fail; 2011 May; 17(5):349-58. PubMed ID: 21549290
[TBL] [Abstract][Full Text] [Related]
3. ACCF/AHA/HFSA 2011 survey results: current staffing profile of heart failure programs, including programs that perform heart transplant and mechanical circulatory support device implantation: a report of the ACCF Heart Failure and Transplant Committee, AHA Heart Failure and Transplantation Committee, and Heart Failure Society of America.
Jessup M; Albert NM; Lanfear DE; Lindenfeld J; Massie BM; Walsh MN; Zucker MJ
Circ Heart Fail; 2011 May; 4(3):378-87. PubMed ID: 21464151
[TBL] [Abstract][Full Text] [Related]
4. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
5. Transitioning to the National Institutes of Health single institutional review board model: Piloting the use of the Streamlined, Multi-site, Accelerated Resources for Trials IRB Reliance.
Vardeny O; Hernandez AF; Cohen LW; Franklin A; Baqai M; Palmer S; Bierer BE; Cobb N
Clin Trials; 2019 Jun; 16(3):290-296. PubMed ID: 30866676
[TBL] [Abstract][Full Text] [Related]
6. Criteria for site selection in industry-sponsored clinical trials: a survey among decision-makers in biopharmaceutical companies and clinical research organizations.
Dombernowsky T; Haedersdal M; Lassen U; Thomsen SF
Trials; 2019 Dec; 20(1):708. PubMed ID: 31829234
[TBL] [Abstract][Full Text] [Related]
7. Palliative Care for Patients With Heart Failure: Results From a Heart Failure Society of America Survey.
Chuzi S; Pensa AV; Allen LA; Cross SH; Feder SL; Warraich HJ
J Card Fail; 2023 Jan; 29(1):112-115. PubMed ID: 35842103
[TBL] [Abstract][Full Text] [Related]
8. Activities and Compensation of Advanced Heart Failure Specialists: Results of the Heart Failure Society of America (HFSA) Survey.
Klein L; Greenberg BH; Konstam MA; Gregory D; Kociol RD; Johnson MR; de Marco T
J Card Fail; 2015 Nov; 21(11):924-9. PubMed ID: 26362520
[TBL] [Abstract][Full Text] [Related]
9. Barriers to Clinical Trial Implementation Among Community Care Centers.
Ebrahimi H; Megally S; Plotkin E; Shivakumar L; Salgia NJ; Zengin ZB; Meza L; Chawla N; Castro DV; Dizman N; Bhagat R; Liv S; Li X; Rock A; Liu S; Tripathi A; Dorff T; Oyer RA; Boehmer L; Pal S; Chehrazi-Raffle A
JAMA Netw Open; 2024 Apr; 7(4):e248739. PubMed ID: 38683608
[TBL] [Abstract][Full Text] [Related]
10. Institutional review board barriers and solutions encountered in the Collaboration Among Pharmacists and Physicians to Improve Outcomes Now Study: a national multicenter practice-based implementation trial.
Maclaughlin EJ; Ardery G; Jackson EA; Ives TJ; Young RB; Fike DS; Carter BL
Pharmacotherapy; 2013 Sep; 33(9):902-11. PubMed ID: 23649880
[TBL] [Abstract][Full Text] [Related]
11. Nonpharmacologic care by heart failure experts.
Riegel B; Moser DK; Powell M; Rector TS; Havranek EP
J Card Fail; 2006 Mar; 12(2):149-153. PubMed ID: 16520265
[TBL] [Abstract][Full Text] [Related]
12. What are the main inefficiencies in trial conduct: a survey of UKCRC registered clinical trials units in the UK.
Duley L; Gillman A; Duggan M; Belson S; Knox J; McDonald A; Rawcliffe C; Simon J; Sprosen T; Watson J; Wood W
Trials; 2018 Jan; 19(1):15. PubMed ID: 29310685
[TBL] [Abstract][Full Text] [Related]
13. A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial.
Crow RA; Hart KA; McDermott MP; Tawil R; Martens WB; Herr BE; McColl E; Wilkinson J; Kirschner J; King WM; Eagle M; Brown MW; Hirtz D; Lochmuller H; Straub V; Ciafaloni E; Shieh PB; Spinty S; Childs AM; Manzur AY; Morandi L; Butterfield RJ; Horrocks I; Roper H; Flanigan KM; Kuntz NL; Mah JK; Morrison L; Darras BT; von der Hagen M; Schara U; Wilichowski E; Mongini T; McDonald CM; Vita G; Barohn RJ; Finkel RS; Wicklund M; McMillan HJ; Hughes I; Pegoraro E; Bryan Burnette W; Howard JF; Thangarajh M; Campbell C; Griggs RC; Bushby K; Guglieri M
Trials; 2018 May; 19(1):291. PubMed ID: 29793540
[TBL] [Abstract][Full Text] [Related]
14. Barriers to participation in industry-sponsored clinical trials in pediatric type 2 diabetes.
Farrell R; Bethin K; Klingensmith G; Tamborlane WV; Gubitosi-Klug R
Pediatr Diabetes; 2017 Nov; 18(7):574-578. PubMed ID: 27807915
[TBL] [Abstract][Full Text] [Related]
15. Ethical issues in phase I oncology research: a comparison of investigators and institutional review board chairpersons.
Kodish E; Stocking C; Ratain MJ; Kohrman A; Siegler M
J Clin Oncol; 1992 Nov; 10(11):1810-6. PubMed ID: 1403062
[TBL] [Abstract][Full Text] [Related]
16. Site selection for heart failure clinical trials in the USA.
Harinstein ME; Butler J; Greene SJ; Fonarow GC; Stockbridge NL; O'Connor CM; Pfeffer MA; Mehra MR; Solomon SD; Yancy CW; Fiuzat M; Mentz RJ; Collins SP; McMurray JJ; Vaduganathan M; Dunnmon PM; Rosano GM; Dinh W; Misselwitz F; Bonow RO; Gheorghiade M
Heart Fail Rev; 2015 Jul; 20(4):375-83. PubMed ID: 25649127
[TBL] [Abstract][Full Text] [Related]
17. Compliance with research standards within gynecologic oncology fellowship: A Gynecologic Oncology Fellowship Research Network (GOFRN) study.
Moulton LJ; Michener CM; Levinson K; Cobb L; Tseng J; Jernigan A
Gynecol Oncol; 2017 Sep; 146(3):647-652. PubMed ID: 28698010
[TBL] [Abstract][Full Text] [Related]
18. Academic medical centers' standards for clinical-trial agreements with industry.
Mello MM; Clarridge BR; Studdert DM
N Engl J Med; 2005 May; 352(21):2202-10. PubMed ID: 15917385
[TBL] [Abstract][Full Text] [Related]
19. Central institutional review board review for an academic trial network.
Kaufmann P; O'Rourke PP
Acad Med; 2015 Mar; 90(3):321-3. PubMed ID: 25406606
[TBL] [Abstract][Full Text] [Related]
20. Variability of the institutional review board process within a national research network.
Khan MA; Barratt MS; Krugman SD; Serwint JR; Dumont-Driscoll M;
Clin Pediatr (Phila); 2014 Jun; 53(6):556-60. PubMed ID: 24658908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
